Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289942103> ?p ?o ?g. }
- W4289942103 endingPage "240.e4" @default.
- W4289942103 startingPage "231" @default.
- W4289942103 abstract "The mid-term results after treatment of isolated popliteal lesions have been limited. The aim of the present study was to report the mid-term outcomes after endovascular treatment of isolated atherosclerotic popliteal artery lesions.A multicenter (15 hospitals in five countries) retrospective cohort study was performed. Between June 2016 and June 2021, 651 consecutive patients who had been treated for isolated popliteal lesions using endovascular methods exclusively were included in the present study. Six techniques were identified, including plain balloon angioplasty (PTA; n = 286; 43.9%), drug-coated balloon angioplasty (n = 98; 15.1%), stenting with low-chronic outward force (COF) stents (n = 84; 12.9%), stenting with high-COF stents (n = 76; 11.7%), atherectomy alone (n = 17; 2.6%), and directional atherectomy with drug-coated balloons (n = 90; 13.8%). The primary outcomes measures were primary and secondary patency and freedom from clinically driven target lesion revascularization (F-CDTLR).The mean patient age was 74.5 years. Most of the patients (n = 409; 62.9%) had had chronic limb-threatening ischemia. Popliteal occlusion was found in 400 cases (61.4%). High-grade calcification was present in 36.7% of cases. Immediate technical success was 94.8%. The median follow-up was 26 months (range, 6-42 months). The actuarial rate for all patients at 26 months (per outcome measure) was as follows: primary patency, 73.9%; secondary patency, 88%; and F-CDTLR, 76.5%. When comparing PTA vs all other treatments in an adjusted regression analysis, the F-CDTLR was 75.2% for PTA vs 76.5% for all other treatment (hazard ratio, 1.06; 95% confidence interval, 0.75-1.48; P = .46, adjusted regression). The difference in secondary patency also was not statistically significant (85.7% for PTA vs 88%; P = .20). Adjusted Kaplan-Meier analysis revealed that the estimated primary patency was inferior for PTA in pairwise comparisons vs other treatments (P < .001 vs atherectomy; P = .002 vs directional atherectomy with drug-coated balloons; and P = .002 vs low-COF stenting).The results from our study have shown that endovascular treatment of isolated popliteal lesions is safe and associated with acceptable patency and F-CDTLR in the mid-term." @default.
- W4289942103 created "2022-08-06" @default.
- W4289942103 creator A5006750448 @default.
- W4289942103 creator A5009379317 @default.
- W4289942103 creator A5013341953 @default.
- W4289942103 creator A5015287907 @default.
- W4289942103 creator A5020994480 @default.
- W4289942103 creator A5021987497 @default.
- W4289942103 creator A5029437934 @default.
- W4289942103 creator A5038478948 @default.
- W4289942103 creator A5046215425 @default.
- W4289942103 creator A5047883586 @default.
- W4289942103 creator A5053241953 @default.
- W4289942103 creator A5053935640 @default.
- W4289942103 creator A5054845354 @default.
- W4289942103 creator A5058199555 @default.
- W4289942103 creator A5064317922 @default.
- W4289942103 creator A5064854422 @default.
- W4289942103 creator A5067657646 @default.
- W4289942103 creator A5076080448 @default.
- W4289942103 creator A5087505202 @default.
- W4289942103 creator A5089934590 @default.
- W4289942103 date "2023-01-01" @default.
- W4289942103 modified "2023-10-16" @default.
- W4289942103 title "Different endovascular modalities of treatment for isolated atherosclerotic popliteal artery lesions (EMO-POP) registry" @default.
- W4289942103 cites W129589342 @default.
- W4289942103 cites W1514973749 @default.
- W4289942103 cites W1870255049 @default.
- W4289942103 cites W2021241283 @default.
- W4289942103 cites W2063860558 @default.
- W4289942103 cites W2156372890 @default.
- W4289942103 cites W2342634071 @default.
- W4289942103 cites W2467122689 @default.
- W4289942103 cites W2498757481 @default.
- W4289942103 cites W2581273032 @default.
- W4289942103 cites W2615684853 @default.
- W4289942103 cites W2750168961 @default.
- W4289942103 cites W2794425698 @default.
- W4289942103 cites W2811597624 @default.
- W4289942103 cites W2896680292 @default.
- W4289942103 cites W2900950825 @default.
- W4289942103 cites W2903318149 @default.
- W4289942103 cites W3014223601 @default.
- W4289942103 cites W3107568115 @default.
- W4289942103 cites W4239553742 @default.
- W4289942103 cites W4244934251 @default.
- W4289942103 cites W4289886312 @default.
- W4289942103 doi "https://doi.org/10.1016/j.jvs.2022.07.170" @default.
- W4289942103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35934215" @default.
- W4289942103 hasPublicationYear "2023" @default.
- W4289942103 type Work @default.
- W4289942103 citedByCount "6" @default.
- W4289942103 countsByYear W42899421032023 @default.
- W4289942103 crossrefType "journal-article" @default.
- W4289942103 hasAuthorship W4289942103A5006750448 @default.
- W4289942103 hasAuthorship W4289942103A5009379317 @default.
- W4289942103 hasAuthorship W4289942103A5013341953 @default.
- W4289942103 hasAuthorship W4289942103A5015287907 @default.
- W4289942103 hasAuthorship W4289942103A5020994480 @default.
- W4289942103 hasAuthorship W4289942103A5021987497 @default.
- W4289942103 hasAuthorship W4289942103A5029437934 @default.
- W4289942103 hasAuthorship W4289942103A5038478948 @default.
- W4289942103 hasAuthorship W4289942103A5046215425 @default.
- W4289942103 hasAuthorship W4289942103A5047883586 @default.
- W4289942103 hasAuthorship W4289942103A5053241953 @default.
- W4289942103 hasAuthorship W4289942103A5053935640 @default.
- W4289942103 hasAuthorship W4289942103A5054845354 @default.
- W4289942103 hasAuthorship W4289942103A5058199555 @default.
- W4289942103 hasAuthorship W4289942103A5064317922 @default.
- W4289942103 hasAuthorship W4289942103A5064854422 @default.
- W4289942103 hasAuthorship W4289942103A5067657646 @default.
- W4289942103 hasAuthorship W4289942103A5076080448 @default.
- W4289942103 hasAuthorship W4289942103A5087505202 @default.
- W4289942103 hasAuthorship W4289942103A5089934590 @default.
- W4289942103 hasConcept C126322002 @default.
- W4289942103 hasConcept C126838900 @default.
- W4289942103 hasConcept C139059822 @default.
- W4289942103 hasConcept C141071460 @default.
- W4289942103 hasConcept C167135981 @default.
- W4289942103 hasConcept C2776268601 @default.
- W4289942103 hasConcept C2777209855 @default.
- W4289942103 hasConcept C2777303625 @default.
- W4289942103 hasConcept C2777466421 @default.
- W4289942103 hasConcept C2778283817 @default.
- W4289942103 hasConcept C2778583881 @default.
- W4289942103 hasConcept C2779464278 @default.
- W4289942103 hasConcept C2780309369 @default.
- W4289942103 hasConcept C2780326628 @default.
- W4289942103 hasConcept C2780400711 @default.
- W4289942103 hasConcept C2781099653 @default.
- W4289942103 hasConcept C2781156865 @default.
- W4289942103 hasConcept C2781464078 @default.
- W4289942103 hasConcept C3018348675 @default.
- W4289942103 hasConcept C500558357 @default.
- W4289942103 hasConcept C71924100 @default.
- W4289942103 hasConcept C72563966 @default.
- W4289942103 hasConceptScore W4289942103C126322002 @default.
- W4289942103 hasConceptScore W4289942103C126838900 @default.